700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
Department of Biochemistry and Molecular Medicine
University of California
Dr Sangita Biswas received her PhD in neuroscience in 1993 from the Institute of Medical Sciences, Varanasi, India. She then underwent postdoctoral work as a Visiting Fellow in Neuroscience department at the University of New South Wales, Australia. Subsequently, she relocated to the United States as a Postdoctoratal Fellow in the Department of Molecular and Integrative Physiology at the University of Kansas Medical Center, Kansas. In 2002, she became a Research Assistant Professor at the University of Kansas Medical Center. During this time she published several important studies on the treatment for Globoid Cell Leukodystrophy and the EAE model of Multiple Sclerosis. In 2004, she joined MidAmerica Neuroscience Institute, Kansas City, as the Director of their Multiple Sclerosis research team. Here she was involved in several early drug development programs for the treatment of multiple sclerosis and other related autoimmune demyelinating diseases. In 2011, she joined as a Senior Scientist at the University of California, Davis. Currently, she is also an investigator at the Shriners Hospital for Children, Sacramento. Her scientific interests are therapeutic interventions for remyelination in demyelinating diseases. Her current projects are centered on direct in vivo and in vitro reprogramming of somatic cells into oligodendrocyte precursor cells. She is also interested in developing human stem cell based therapies in demyelinating diseases such as Multiple Sclerosis. She also makes every effort toward translating fundamental insights into discovery of new therapeutic strategies for human disorders.
Molecular Mechanisms of Neurological Disorders, new therapeutic strategies for human disorders, treatment of multiple sclerosis
Global Speakers in the subject
Global Experts in the subject